Mistakes can happen, so when using your injection pen, double-check that the dose showing in the dose window matches the amount your provider prescribed
doi: 10.1056/NEJMoa2206038 47 WillardFSDourosJDGabeMBShowalterADWainscottDBSuterTMet al
L., Casu, C., Oosterhuis, D., Mleczko-Sanecka, K., et al
Kuckelman added that with the lawsuit, Novo isnt aiming to stop all compounding practices, saying, I would just say we do want an end to mass compounding, to unlawful mass compounding. On the opposite side of things, Arizona-based Strive Compounding Pharmacy filed a lawsuit last month, alleging Eli Lilly and Novo Nordisk are engaging in a coordinated effort to suppress competition. Strive filed the complaint in the U.S
GLP-1 receptor agonists are making headlines